Antisense oligonucleotides targeting the progesterone receptor inhibit hormone-independent breast cancer growth in mice.

Lamb CA, Helguero LA, Giulianelli S, Soldati R, Vanzulli SI, Molinolo A, Lanari C.

Breast Cancer Res. 2005;7(6):R1111-21. Epub 2005 Nov 9.

PMID: 16457691 [PubMed - indexed for MEDLINE]

Related Articles Free article in PMC

Progesterone receptor involvement in independent tumor growth in MPA-induced murine mammary adenocarcinomas.

Montecchia MF, Lamb C, Molinolo AA, Luthy IA, Pazos P, Charreau E, Vanzulli S, Lanari C.

J Steroid Biochem Mol Biol. 1999 Jan;68(1-2):11-21.

PMID: 10215033 [PubMed - indexed for MEDLINE]

Related Articles

Association of estrogen receptor-alpha and progesterone receptor A expression with hormonal mammary carcinogenesis: role of the host microenvironment.

Montero Girard G, Vanzulli SI, Cerliani JP, Bottino MC, Bolado J, Vela J, Becu-Villalobos D, Benavides F, Gutkind S, Patel V, Molinolo A, Lanari C.

Breast Cancer Res. 2007;9(2):R22.

PMID: 17341305 [PubMed - indexed for MEDLINE]

Related Articles Free article in PMC

Reversal of estrogen-resistance in murine mammary adenocarcinomas.

Montecchia MF, Molinolo A, Lanari C.

Breast Cancer Res Treat. 1999 Mar;54(2):93-9.

PMID: 10424399 [PubMed - indexed for MEDLINE]

Related Articles

Regulation of cell growth of a progestin-dependent murine mammary carcinoma in vitro: progesterone receptor involvement in serum or growth factor-induced cell proliferation.

Lamb C, Simian M, Molinolo A, Pazos P, Lanari C.

J Steroid Biochem Mol Biol. 1999 Sep-Oct;70(4-6):133-42.

PMID: 10622401 [PubMed - indexed for MEDLINE]

Related Articles

[Progestin-induced mammary adenocarcinomas in BALB/c mice. Progression from hormone-dependent to autonomous tumors]

Lanari C, Montecchia MF, Pazos P, Simian M, Vanzulli S, Lamb C, Molinolo AA.

Medicina (B Aires). 1997;57 Suppl 2:55-69. Spanish.

PMID: 9567344 [PubMed - indexed for MEDLINE]

Related Articles

Progesterone induction of mammary carcinomas in BALB/c female mice. Correlation between progestin dependence and morphology.

Kordon EC, Molinolo AA, Pasqualini CD, Charreau EH, Pazos P, Dran G, Lanari C.

Breast Cancer Res Treat. 1993 Oct;28(1):29-39.

PMID: 8123867 [PubMed - indexed for MEDLINE]

Related Articles

Keratinocyte growth factor (KGF) induces tamoxifen (Tam) resistance in human breast cancer MCF-7 cells.

Chang HL, Sugimoto Y, Liu S, Ye W, Wang LS, Huang YW, Lin YC.

Anticancer Res. 2006 May-Jun;26(3A):1773-84.

PMID: 16827106 [PubMed - indexed for MEDLINE]

Related Articles

Progestin-induced caveolin-1 expression mediates breast cancer cell proliferation.

Salatino M, Beguelin W, Peters MG, Carnevale R, Proietti CJ, Galigniana MD, Vedoy CG, Schillaci R, Charreau EH, Sogayar MC, Elizalde PV.

Oncogene. 2006 Dec 14;25(59):7723-39. Epub 2006 Jun 26.

PMID: 16799639 [PubMed - indexed for MEDLINE]

Related Articles

Progesterone receptor expression in medroxyprogesterone acetate-induced murine mammary carcinomas and response to endocrine treatment.

Helguero LA, Viegas M, Asaithamby A, Shyamala G, Lanari C, Molinolo AA.

Breast Cancer Res Treat. 2003 Jun;79(3):379-90.

PMID: 12846422 [PubMed - indexed for MEDLINE]

Related Articles

Embryonal mass and hormone-associated effects of pregnancy inducing a differential growth of four murine tumors.

Bustuoabad OD, di Gianni PD, Franco M, Kordon EC, Vanzulli SI, Meiss RP, Grion LC, Díaz GS, Nosetto SH, Hockl P, Lombardi MG, Pasqualini CD, Ruggiero RA.

Oncol Res. 2002;13(3):147-60.

PMID: 12549624 [PubMed - indexed for MEDLINE]

Related Articles

Immunization with murine breast cancer cells treated with antisense oligodeoxynucleotides to type I insulin-like growth factor receptor induced an antitumoral effect mediated by a CD8+ response involving Fas/Fas ligand cytotoxic pathway.

Schillaci R, Salatino M, Cassataro J, Proietti CJ, Giambartolomei GH, Rivas MA, Carnevale RP, Charreau EH, Elizalde PV.

J Immunol. 2006 Mar 15;176(6):3426-37.

PMID: 16517711 [PubMed - indexed for MEDLINE]

Related Articles

Re-activation of the p53 pathway inhibits in vivo and in vitro growth of hormone-dependent human breast cancer cells.

Liang Y, Besch-Williford C, Benakanakere I, Hyder SM.

Int J Oncol. 2007 Oct;31(4):777-84.

PMID: 17786308 [PubMed - indexed for MEDLINE]

Related Articles

Sulindac sulfide and exisulind inhibit expression of the estrogen and progesterone receptors in human breast cancer cells.

Lim JT, Joe AK, Suzui M, Shimizu M, Masuda M, Weinstein IB.

Clin Cancer Res. 2006 Jun 1;12(11 Pt 1):3478-84.

PMID: 16740773 [PubMed - indexed for MEDLINE]

Related Articles

Role for HER2/neu and HER3 in fulvestrant-resistant breast cancer.

Osipo C, Meeke K, Cheng D, Weichel A, Bertucci A, Liu H, Jordan VC.

Int J Oncol. 2007 Feb;30(2):509-20.

PMID: 17203234 [PubMed - indexed for MEDLINE]

Related Articles

[Type I insulin-like growth factor receptor antisense strategies in experimental breast cancer]

Salatino M, Schillaci R, Proietti CJ, Carnevale R, Charreau EH, Elizalde PV.

Medicina (B Aires). 2004;64(2):129-34. Spanish.

PMID: 15628299 [PubMed - indexed for MEDLINE]

Related Articles

Flaxseed alone or in combination with tamoxifen inhibits MCF-7 breast tumor growth in ovariectomized athymic mice with high circulating levels of estrogen.

Chen J, Power KA, Mann J, Cheng A, Thompson LU.

Exp Biol Med (Maywood). 2007 Sep;232(8):1071-80.

PMID: 17720953 [PubMed - indexed for MEDLINE]

Related Articles

Effects of different durations of estrogen and progesterone treatment on development of N-methyl-N-nitrosourea-induced mammary carcinomas in female Lewis rats.

Yuri T, Tsukamoto R, Uehara N, Matsuoka Y, Tsubura A.

In Vivo. 2006 Nov-Dec;20(6B):829-36.

PMID: 17203775 [PubMed - indexed for MEDLINE]

Related Articles

Progestin-dependent progression of human breast tumor xenografts: a novel model for evaluating antitumor therapeutics.

Liang Y, Besch-Williford C, Brekken RA, Hyder SM.

Cancer Res. 2007 Oct 15;67(20):9929-36.

PMID: 17942925 [PubMed - indexed for MEDLINE]

Related Articles

Progestin effects on breast cancer cell proliferation, proteases activation, and in vivo development of metastatic phenotype all depend on progesterone receptor capacity to activate cytoplasmic signaling pathways.

Carnevale RP, Proietti CJ, Salatino M, Urtreger A, Peluffo G, Edwards DP, Boonyaratanakornkit V, Charreau EH, Bal de Kier Joffé E, Schillaci R, Elizalde PV.

Mol Endocrinol. 2007 Jun;21(6):1335-58. Epub 2007 Apr 17.

PMID: 17440047 [PubMed - indexed for MEDLINE]

Related Articles